SINTX TECHNOLOGIES, INC Research and Development Expenses 2012-2024 | SINT

SINTX TECHNOLOGIES, INC research and development expenses from 2012 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

SINTX TECHNOLOGIES, INC Research and Development Expenses 2012-2024 | SINT

SINTX TECHNOLOGIES, INC research and development expenses from 2012 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$211B
Intuitive Surgical (ISRG)$191.1B
Alcon (ALC)$45.7B
IQVIA Holdings (IQV)$39.8B
Edwards Lifesciences (EW)$39.1B
IDEXX Laboratories (IDXX)$35.5B
DexCom (DXCM)$27.3B
Waters (WAT)$22.8B
SONOVA HOLDING (SONVY)$22.1B
STERIS (STE)$21.6B
Hologic (HOLX)$18.3B
Sysmex ADR (SSMXY)$12.9B
Fresenius Medical Care AG KGaA (FMS)$12.5B
Globus Medical (GMED)$11B
Teleflex (TFX)$9.1B
Penumbra (PEN)$9.1B
Masimo (MASI)$8.7B
Glaukos (GKOS)$7.8B
PROCEPT BioRobotics (PRCT)$5.2B
Integer Holdings (ITGR)$4.6B
Inari Medical (NARI)$3B
TransMedics (TMDX)$2.9B
LivaNova (LIVN)$2.8B
Veracyte (VCYT)$2.8B
Nihon Kohden (NHNKY)$2.6B
Elekta AB (EKTAY)$2.3B
Tandem Diabetes Care (TNDM)$2B
Integra LifeSciences Holdings (IART)$1.9B
RxSight (RXST)$1.8B
Alphatec Holdings (ATEC)$1.3B